{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:06:59Z","timestamp":1788314819438,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007335","name":"Ministry of Higher Education and Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007335","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jogc.2025.102963","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:47:26Z","timestamp":1750261646000},"page":"102963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prospective Study Evaluating the Association Between sFlt-1\/PlGF Ratio and Adverse Outcomes in Preterm Preeclampsia"],"prefix":"10.1016","volume":"47","author":[{"given":"Louise","family":"Ghesqui\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6936-4369","authenticated-orcid":false,"given":"Emmanuel","family":"Bujold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcef","family":"Djedid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afef","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayen","family":"Magherbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feirouz","family":"Ayari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalenda","family":"Chelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2025.102963_bib1","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jogc.2025.102963_bib2","series-title":"Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA\/Population Division","year":"2023"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2025.102963_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2025.102963_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jogc.2025.102963_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(23)00688-8","article-title":"Planned delivery or expectant management for late preterm pre-eclampsia in low-income and middle-income countries (CRADLE-4): a multicentre, open-label, randomised controlled trial","volume":"402","author":"Beardmore-Gray","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2025.102963_bib6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2025.102963_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2025.102963_bib8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2025.102963_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.jogc.2025.102963_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2025.102963_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2024.102753","article-title":"First-trimester soluble fms-like tyrosine kinase 1 (sFlt-1) for the prediction of preterm preeclampsia","volume":"47","author":"Fillion","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2025.102963_bib12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jogc.2017.07.014","article-title":"First and second trimester serum sFlt-1\/PlGF ratio and subsequent preeclampsia: a systematic review","volume":"40","author":"Yusuf","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2025.102963_bib13","doi-asserted-by":"crossref","first-page":"363.e1","DOI":"10.1016\/j.ajog.2024.05.050","article-title":"Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing","volume":"231","author":"Espinoza","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2025.102963_bib14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2025.102963_bib15","article-title":"Correlation of sFlt\/PlGF ratio with severity of preeclampsia in an Indian population","volume":"3","author":"Kumar","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.jogc.2025.102963_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2024.102759","article-title":"Proposed utilization of PlGF-based diagnostic testing for suspected preeclampsia in Qu\u00e9bec: insights from an expert panel discussion","volume":"47","author":"Malham\u00e9","year":"2025","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2025.102963_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jogc.2025.102963_bib18","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/HYPERTENSIONAHA.111.00754","article-title":"Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia","volume":"61","author":"Lea\u00f1os-Miranda","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2025.102963_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.preghy.2013.02.003","article-title":"sFlt-1\/PlGF ratio as a prognostic marker of adverse outcomes in women with early-onset preeclampsia","volume":"3","author":"De Oliveira","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.jogc.2025.102963_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/uog.13224","article-title":"Uterine artery Doppler and sFlt-1\/PlGF ratio: prognostic value in early-onset pre-eclampsia","volume":"43","author":"G\u00f3mez-Arriaga","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2025.102963_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preghy.2020.07.007","article-title":"sFlt-1\/PlGF ratio for the prediction of delivery within 48 hours and adverse outcomes in expectantly managed early-onset preeclampsia","volume":"22","author":"Sim\u00f3n","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.jogc.2025.102963_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00404-019-05365-9","article-title":"Role of sFlt-1\/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia","volume":"301","author":"Graupner","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogc.2025.102963_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jogc.2025.102963_bib24","doi-asserted-by":"crossref","first-page":"e292","DOI":"10.1055\/s-0040-1709696","article-title":"Evaluation of the prognostic value of the sFlt-1\/PlGF ratio in early-onset preeclampsia","volume":"38","author":"Tasta","year":"2021","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jogc.2025.102963_bib25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/uog.24851","article-title":"Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia","volume":"59","author":"Reddy","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2025.102963_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000529781","article-title":"Comparison of the soluble fms-Like tyrosine kinase 1\/placental growth factor ratio alone versus a multi-marker regression model for the prediction of preeclampsia-related adverse outcomes after 34 weeks of gestation","volume":"50","author":"Sroka","year":"2023","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2025.102963_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/uog.26276","article-title":"Longitudinal assessment of angiogenic markers in prediction of adverse outcome in women with confirmed pre-eclampsia","volume":"62","author":"Binder","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2025.102963_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.jogc.2025.102963_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/ijmm.2023.5292","article-title":"Predictive value of the sFlt-1\/PlGF ratio in women with suspected preeclampsia: an update (review)","volume":"52","author":"Velegrakis","year":"2023","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jogc.2025.102963_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jogc.2020.03.024","article-title":"Placental growth factor and soluble, Fms-like tyrosine kinase-1 in preeclampsia: a case-cohort (PEARL) study","volume":"42","author":"Fillion","year":"2020","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216325002099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216325002099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:53:28Z","timestamp":1762556008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216325002099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1701216325002099"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2025.102963","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Study Evaluating the Association Between sFlt-1\/PlGF Ratio and Adverse Outcomes in Preterm Preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2025.102963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Inc. on behalf of The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada.","name":"copyright","label":"Copyright"}],"article-number":"102963"}}